Literature DB >> 23062294

The role of limbic system irritability in linking history of childhood maltreatment and psychiatric outcomes in low-income, high-risk women: moderation by FK506 binding protein 5 haplotype.

Melissa N Dackis1, Fred A Rogosch, Assaf Oshri, Dante Cicchetti.   

Abstract

Childhood maltreatment is associated with lasting changes in neuroendocrine regulation, alterations in brain structure and function, and symptoms of "limbic irritability." Limbic irritability symptoms include somatic, sensory, and behavioral phenomena and may stem from increased excitatory neurotransmission following maltreatment. We tested the hypotheses that child maltreatment is indirectly associated with depressive and dissociative symptomatology via indicators of limbic irritability and that variation within the FK506 binding protein 5 gene (FKBP5), a gene involved in glucorticoid receptor functioning, moderates these effects. The sample consisted of high-risk, low-income women (N = 236) living in an inner-city environment. Child maltreatment, limbic irritability, and symptoms of depression and dissociation were measured cross-sectionally using self-report assessments. Haplotype analyses were conducted across four FKBP5 single nucleotide polymorphisms: rs3800373, rs9296158, rs1360870, and rs9470080. Path analysis using bootstrapping procedures was performed to test hypotheses regarding indirect and conditional indirect effects. We found significant indirect effects of maltreatment on depression (β = 0.088, p < .01) and dissociation (β = 0.105, p < .01) via limbic irritability. In addition, variation within FKBP5 moderated these significant indirect effects. For individuals with one to two copies of the CATT haplotype, the indirect effects of maltreatment on depression (β = 0.137, p < .01) and dissociation (β = 0.132, p < .01) via limbic irritability were significant, whereas the indirect paths were not significant for individuals with no copies of this haplotype (depression: β = 0.037, p > .05; dissociation: β = 0.002, p > .05). These results add to the growing evidence that child maltreatment may lead to symptoms of internalizing psychopathology through its impact on the limbic system. In addition, this study revealed a potential role of FKBP5 gene variants in contributing to risk for limbic system dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062294      PMCID: PMC3697116          DOI: 10.1017/S0954579412000673

Source DB:  PubMed          Journal:  Dev Psychopathol        ISSN: 0954-5794


  133 in total

1.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

Review 2.  The past achievements and future promises of developmental psychopathology: the coming of age of a discipline.

Authors:  Dante Cicchetti; Sheree L Toth
Journal:  J Child Psychol Psychiatry       Date:  2008-11-01       Impact factor: 8.982

3.  Emotion regulation among school-age children: the development and validation of a new criterion Q-sort scale.

Authors:  A Shields; D Cicchetti
Journal:  Dev Psychol       Date:  1997-11

4.  Hippocampal volume in women victimized by childhood sexual abuse.

Authors:  M B Stein; C Koverola; C Hanna; M G Torchia; B McClarty
Journal:  Psychol Med       Date:  1997-07       Impact factor: 7.723

5.  The effects of child maltreatment on early signs of antisocial behavior: genetic moderation by tryptophan hydroxylase, serotonin transporter, and monoamine oxidase A genes.

Authors:  Dante Cicchetti; Fred A Rogosch; Eric L Thibodeau
Journal:  Dev Psychopathol       Date:  2012-08

6.  A longitudinal study of emotion regulation, emotion lability-negativity, and internalizing symptomatology in maltreated and nonmaltreated children.

Authors:  Jungmeen Kim-Spoon; Dante Cicchetti; Fred A Rogosch
Journal:  Child Dev       Date:  2012-10-03

Review 7.  The neurobiological consequences of early stress and childhood maltreatment.

Authors:  Martin H Teicher; Susan L Andersen; Ann Polcari; Carl M Anderson; Carryl P Navalta; Dennis M Kim
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

8.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Authors:  Magnus Lekman; Gonzalo Laje; Dennis Charney; A John Rush; Alexander F Wilson; Alexa J M Sorant; Robert Lipsky; Stephen R Wisniewski; Husseini Manji; Francis J McMahon; Silvia Paddock
Journal:  Biol Psychiatry       Date:  2008-01-11       Impact factor: 13.382

Review 10.  Gene-environment interaction in posttraumatic stress disorder: an update.

Authors:  Karestan C Koenen; Ananda B Amstadter; Nicole R Nugent
Journal:  J Trauma Stress       Date:  2009-09-09
View more
  24 in total

Review 1.  Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.

Authors:  Anthony S Zannas; Tobias Wiechmann; Nils C Gassen; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2015-08-13       Impact factor: 7.853

2.  Moderation of maltreatment effects on childhood borderline personality symptoms by gender and oxytocin receptor and FK506 binding protein 5 genes.

Authors:  Dante Cicchetti; Fred A Rogosch; Kathryn F Hecht; Nicki R Crick; Susan Hetzel
Journal:  Dev Psychopathol       Date:  2014-08

3.  From child maltreatment to emerging adult problem drinking: Identification of a multilevel internalizing pathway among African American youth.

Authors:  Elizabeth D Handley; Fred A Rogosch; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2017-12

4.  Investigating multilevel pathways of developmental consequences of maltreatment.

Authors:  Carrie E DePasquale; Elizabeth D Handley; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2019-10

5.  Maltreatment timing, HPA axis functioning, multigenic risk, and depressive symptoms in African American youth: Differential associations without moderated mediation.

Authors:  Adrienne A VanZomeren; Jingchen Zhang; Sun-Kyung Lee; Meredith Gunlicks-Stoessel; Timothy Piehler; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2020-12

6.  A genome-wide association study of clinical symptoms of dissociation in a trauma-exposed sample.

Authors:  Erika J Wolf; Ann M Rasmusson; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Mark W Miller
Journal:  Depress Anxiety       Date:  2014-03-27       Impact factor: 6.505

7.  Childhood maltreatment type and severity predict depersonalization and derealization in treatment-seeking women with posttraumatic stress disorder.

Authors:  Christopher D King; Sarah B Hill; Jonathan D Wolff; Cara E Bigony; Sherry Winternitz; Kerry J Ressler; Milissa L Kaufman; Lauren A M Lebois
Journal:  Psychiatry Res       Date:  2020-07-17       Impact factor: 3.222

Review 8.  Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: A systematic review and meta-analysis.

Authors:  Qingzhong Wang; Richard C Shelton; Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2017-08-24       Impact factor: 4.839

9.  CHILDHOOD MALTREATMENT PREDICTS REDUCED INHIBITION-RELATED ACTIVITY IN THE ROSTRAL ANTERIOR CINGULATE IN PTSD, BUT NOT TRAUMA-EXPOSED CONTROLS.

Authors:  Jennifer S Stevens; Timothy D Ely; Takehito Sawamura; Dora Guzman; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  Depress Anxiety       Date:  2016-04-08       Impact factor: 6.505

10.  Disorganized attachment in infancy predicts greater amygdala volume in adulthood.

Authors:  K Lyons-Ruth; P Pechtel; S A Yoon; C M Anderson; M H Teicher
Journal:  Behav Brain Res       Date:  2016-04-06       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.